1991 Doctor Degree in Medicine, Tongji Medical University, Wuhan, China.

1991-1996: Resident, Attending physician, Chief physician and Professor, Division of Hematology, Second Affiliated Hospital of Shanxi Medical College, Taiyuan, China.

1996-1998: Visiting Scientist, Laboratory of Dr. Hans Messner, in the Unit of Bone marrow Transplantation, Ontario Cancer Institute, Toronto, Canada.

1998-presence: Director, Division of Hematology, Shanghai Jiaotong University affiliated Shanghai General Hospital，Chairman of the Shanghai Society of Hematology

The research programs: The experimental and clinical researches of hematopoietic stem cell transplantation (HSCT). The HSCT Programs consist of  autologous and allogeneic bone marrow, peripheral blood stem cell，and cord blood cell transplantation(CBT).

Bacterial Pathogens Differed Between Neutropenic and Non-neutropenic Patients in the Same Hematological Ward: An 8-Year Survey. CID 2018; 67 (Suppl 2) • S175.

Effect of Granulocyte-Macrophage Colony-Stimulating Factor on Prevention and Treatment of Invasive Fungal Disease in Recipients of Allogeneic Stem-Cell Transplantation: A Prospective Multicenter Randomized Phase IV Trial. J Clin Oncol. 2015; 33(34):3999-4006.

Anti-thymocyte globulin could improve the outcome of allogeneic hematopoietic stem cell transplantation in patients with highly aggressive T-cell tumors。Blood Cancer Journal 2015； 5, e332。

Chun Wang on Oncology in China. Lancet Oncol. 2001; 2(7), 450-453.